I don't know much about this but I see no reason why the effect on brain cells should not be within about 20 minutes (less on an empty stomach?) .... I think we may forget that a lot of signals between cells are being packaged, sent and broken down all within a matter of minutes or even less. As soon as you block the constant message sending the effect stops..
Thanks for replying. I am taking the LDN in liquid form (tabs dissolved in distilled water) and have opted to hold the dose under my tongue until it is mostly all absorbed - doing it this way is supposed to lessen the risk of gastric effects, but I guess it also means the drug could start acting more quickly.
Good point about the signalling timeframe.
I have been looking around the interwebs, and found an interesting observation by Dr Tom Gilhooly, a GP in Glasgow with a lot of interest in LDN, originally in addiction and now in MS. At the 2nd European LDN conference he said the following, based on research by J Younger,
Tom Gilhooly said:
LDN is a “racemic mix” of mirror image right- and left-handed molecules. This is common in chemistry, and most drugs consist of such a natural mix. It is usual for only one of the sides to be biologically active, but in the case of LDN, both sides are active.
The right handed molecule blocks the opiate receptors, which confer the action the drug is licensed for i.e., blocking the action of heroin and other illicit opiates.
The more interesting part regards the left-handed molecule, which acts on the Toll-like 4 receptors on the surface of immune cells and acts as an immune modulator.
Dr Younger studied the effect on microglial cells, a type of immune cell important to the neurological system, which becomes active when the immune system is activated. ... The left-handed Naltrexone binds to these receptors and reduces the inflammatory chemicals that are pouring out of these cells. This idea makes great sense and fits very well with our findings in the clinic. If this is the mode of action, it fits with the hypothesis of Dr Agrawal and others… This is a big discovery…
This would suggest that the opiate-blocking effect of LDN is actually the limiting factor on dose and we should aim to get the highest dose possible that the patient can tolerate, to produce the greatest effect on the immune system.
So it seems he was thinking along the same sort of lines as we are here: increasing the dose of LDN, or taking small doses more often through the day, would block the TLR4 receptors for longer, yielding more benefit.
(If this proved to be as relevant as it seems it may be, then presumably the ideal would be if the isomers could be separated out, resulting in benefit from the TLR4 blocking without the opiate blockade.)